| P50 | author | Matthias Egger | Q19996372 |
| | Andrew Boulle | Q53680127 |
| | Ralf Weigel | Q55135759 |
| | Catherine Orrell | Q55135761 |
| | François Dabis | Q56850448 |
| P2093 | author name string | Colin Mathers | |
| | Eugène Messou | |
| | Martin W G Brinkhof | |
| | Margaret Pascoe | |
| P2860 | cites work | Projections of global mortality and burden of disease from 2002 to 2030 | Q21144688 |
| | Mortality in relation to smoking: 50 years' observations on male British doctors | Q24563394 |
| | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| | Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study | Q24645600 |
| | Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data | Q28242645 |
| | Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared | Q28473120 |
| | Average volume of alcohol consumption, patterns of drinking, and all-cause mortality: results from the US National Alcohol Survey | Q31834514 |
| | Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review | Q33302944 |
| | Overestimates of survival after HAART: implications for global scale-up efforts | Q33322531 |
| | Estimating confidence limits on a standardised mortality ratio when the expected number is not error free | Q33702481 |
| | Men's sexual health matters: promoting reproductive health in an international context. | Q34018014 |
| | Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population | Q34547175 |
| | Physical inactivity, excess adiposity and premature mortality. | Q35597677 |
| | Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe | Q35690043 |
| | Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa | Q37012911 |
| | Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America | Q37043395 |
| | Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi | Q37063420 |
| | Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: Recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections | Q57210146 |
| | All cause mortality in the Swiss HIV cohort study from 1990 to 2001 in comparison with the Swiss population | Q57794046 |
| | Mortality and educational level among diabetic and non-diabetic population in the Turin Longitudinal Study: a 9-year follow-up | Q59711308 |
| | Mortality in Patients With Successful Initial Response to Highly Active Antiretroviral Therapy Is Still Higher Than in Non-HIV-Infected Individuals | Q63364000 |
| | Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy: standardization to the general population | Q73968256 |
| | High AIDS-related mortality among young women in rural KwaZulu-Natal | Q81476065 |
| | Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. | Q51809092 |
| | Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population | Q56535269 |
| | Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries | Q37108925 |
| | Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa | Q37265947 |
| | Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration | Q38876759 |
| | Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths | Q39110533 |
| | Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa | Q39753822 |
| | Mortality of white South African gold miners | Q42788667 |
| | Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire. | Q43761484 |
| | Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte dʼIvoire | Q46369733 |
| | Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries | Q46391119 |
| | Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa | Q46887634 |
| | Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia | Q46909093 |
| | Regression models for relative survival | Q47296894 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| | Sub-Saharan Africa | Q132959 |
| | anti-retroviral agent | Q50430310 |
| P304 | page(s) | e1000066 | |
| P577 | publication date | 2009-04-28 | |
| P1433 | published in | PLOS MEDICINE | Q1686921 |
| P1476 | title | Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality | |
| P478 | volume | 6 | |